Recommended content

New FDA cannabis guidance (Newsletter: January 24, 2023)

VA eyeing psychedelics guidance & research; New PA gov talks marijuana pardons; Study: Cannabis enhances sex; ND hemp flag resolution

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.

Paul Travaglino of Enlightened Foods: “Marijuana Moment is our ‘finger on the pulse.’ It’s a must-read before we start our day.”


The Food and Drug Administration published final guidance on clinical research to develop cannabis-based drugs.

A top Department of Veterans Affairs mental health official said the agency is keeping a “very close eye” on psychedelics—including exploring new guidance to ensure veterans are protected from losing federal benefits over the use of substances like psilocybin.


Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment

More news